Driehaus Capital Management’s Acceleron Pharma XLRN Stock Holding History

Driehaus Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-57,715	Closed	-$2.2M	–	607
2015 Q1	$2.2M	Sell	57,715 -138,672	-71%	-$5.51M	0.08%	313
2014 Q4	$7.65M	Buy	196,387 +96,846	+97%	+$3.38M	0.31%	77
2014 Q3	$3.01M	Sell	99,541 -64,741	-39%	-$1.82M	0.11%	237
2014 Q2	$5.58M	Buy	164,282 +40,281	+32%	+$1.35M	0.18%	154
2014 Q1	$4.28M	Sell	124,001 -73,218	-37%	-$3.3M	0.13%	194
2013 Q4	$7.81M	Buy	197,219 +1,817	+0.9%	+$43.9K	0.28%	102
2013 Q3	$4.34M	Buy	+195,402	New	+$4.22M	0.17%	182

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PVMCI

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Driehaus Capital Management's XLRN Position: Q2 2015 in Review

Driehaus Capital Management sold out of Acceleron Pharma (XLRN) in Q2 2015, closing a stake of 57,715 shares — an estimated $2.2M sold.

Driehaus Capital Management first reported a position in XLRN in Q3 2013 and held it in 7 quarters. The position peaked at $7.81M in Q4 2013. 117 funds tracked by Wall St. Rank hold XLRN as of Q2 2015.

Driehaus Capital Management reported no remaining Acceleron Pharma position as of Q2 2015 after selling out during the quarter.
Driehaus Capital Management sold 57,715 Acceleron Pharma shares in Q2 2015, an estimated $2.2M.
Driehaus Capital Management first reported a position in Acceleron Pharma in Q3 2013 and held it in 7 quarters.
Driehaus Capital Management's Acceleron Pharma position peaked at $7.81M in Q4 2013.
117 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2015.

Based on Driehaus Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.